换一批
换一批Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study.
作者：
主题词
投药, 膀胱内(Administration, Intravesical);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡介苗(BCG Vaccine);癌(Carcinoma);化学疗法, 辅助(Chemotherapy, Adjuvant);膀胱切除术(Cystectomy);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);表柔比星(Epirubicin);女(雌)性(Female);人类(Humans);干扰素α(Interferon-alpha);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);肿瘤复发, 局部(Neoplasm Recurrence, Local);肿瘤分期(Neoplasm Staging);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);重组蛋白质类(Recombinant Proteins);危险性评估(Risk Assessment);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome);肿瘤负荷(Tumor Burden);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1016/j.eururo.2009.09.038
PMID
19819617
发布时间
2022-03-30
- 浏览62
European urology
25-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
